Methotrexate Displacement in Man

^{Department of Pharmacology, Yale University School of Medicine, New Haven, Conn.}

^{Department of Medicine, Yale University School of Medicine, New Haven, Conn.}

Research fellow of the National Cancer Institute of Canada and of Yale University (U. S. Public Health Service research training grant 5-T1-GM-59-04).

Present address: The Princess Margaret Hospital, Toronto, Canada.

Submitted for publication October 7, 1963; accepted November 29, 1963.

This investigation was supported in part by a U. S. Public Health Service research grant (CA-02817) and in part by a research grant from the Lederle Laboratories Division, American Cyanamid Co., Pearl River, N. Y. Some of the experimental subjects were studied in the Yale Clinical Research Center, supported by a grant (FR38-03) of the U. S. Public Health Service.

Find articles by Johns, D. in: JCI | PubMed | Google Scholar

^{Department of Pharmacology, Yale University School of Medicine, New Haven, Conn.}

^{Department of Medicine, Yale University School of Medicine, New Haven, Conn.}

Research fellow of the National Cancer Institute of Canada and of Yale University (U. S. Public Health Service research training grant 5-T1-GM-59-04).

Present address: The Princess Margaret Hospital, Toronto, Canada.

Submitted for publication October 7, 1963; accepted November 29, 1963.

This investigation was supported in part by a U. S. Public Health Service research grant (CA-02817) and in part by a research grant from the Lederle Laboratories Division, American Cyanamid Co., Pearl River, N. Y. Some of the experimental subjects were studied in the Yale Clinical Research Center, supported by a grant (FR38-03) of the U. S. Public Health Service.

Find articles by Hollingsworth, J. in: JCI | PubMed | Google Scholar

^{Department of Pharmacology, Yale University School of Medicine, New Haven, Conn.}

^{Department of Medicine, Yale University School of Medicine, New Haven, Conn.}

Research fellow of the National Cancer Institute of Canada and of Yale University (U. S. Public Health Service research training grant 5-T1-GM-59-04).

Present address: The Princess Margaret Hospital, Toronto, Canada.

Submitted for publication October 7, 1963; accepted November 29, 1963.

This investigation was supported in part by a U. S. Public Health Service research grant (CA-02817) and in part by a research grant from the Lederle Laboratories Division, American Cyanamid Co., Pearl River, N. Y. Some of the experimental subjects were studied in the Yale Clinical Research Center, supported by a grant (FR38-03) of the U. S. Public Health Service.

Find articles by Cashmore, A. in: JCI | PubMed | Google Scholar

^{Department of Pharmacology, Yale University School of Medicine, New Haven, Conn.}

^{Department of Medicine, Yale University School of Medicine, New Haven, Conn.}

Research fellow of the National Cancer Institute of Canada and of Yale University (U. S. Public Health Service research training grant 5-T1-GM-59-04).

Present address: The Princess Margaret Hospital, Toronto, Canada.

Submitted for publication October 7, 1963; accepted November 29, 1963.

This investigation was supported in part by a U. S. Public Health Service research grant (CA-02817) and in part by a research grant from the Lederle Laboratories Division, American Cyanamid Co., Pearl River, N. Y. Some of the experimental subjects were studied in the Yale Clinical Research Center, supported by a grant (FR38-03) of the U. S. Public Health Service.

Find articles by Plenderleith, I. in: JCI | PubMed | Google Scholar

^{Department of Pharmacology, Yale University School of Medicine, New Haven, Conn.}

^{Department of Medicine, Yale University School of Medicine, New Haven, Conn.}

Research fellow of the National Cancer Institute of Canada and of Yale University (U. S. Public Health Service research training grant 5-T1-GM-59-04).

Present address: The Princess Margaret Hospital, Toronto, Canada.

Submitted for publication October 7, 1963; accepted November 29, 1963.

This investigation was supported in part by a U. S. Public Health Service research grant (CA-02817) and in part by a research grant from the Lederle Laboratories Division, American Cyanamid Co., Pearl River, N. Y. Some of the experimental subjects were studied in the Yale Clinical Research Center, supported by a grant (FR38-03) of the U. S. Public Health Service.

Find articles by Bertino, J. in: JCI | PubMed | Google Scholar